Mengxi Zhao
Overview
Explore the profile of Mengxi Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Cai X, Zhou M, Chen Y, Pi J, Zhao M, et al.
CNS Neurosci Ther
. 2025 Feb;
31(2):e70226.
PMID: 39976242
Background And Objectives: The relationship of cardiac function with cerebral small vessel disease (CSVD) remains unknown. The study aimed to investigate the association between left ventricular (LV) function and CSVD...
2.
Wang X, Wang Y, Xie M, Ma S, Zhang Y, Wang L, et al.
Cell Death Dis
. 2024 Nov;
15(11):794.
PMID: 39500892
Polycomb repressive complex 2 (PRC2) catalyzes the writing of the tri-methylated histone H3 at Lys27 (H3K27me3) epigenetic marker and suppresses the expression of genes, including tumor suppressors. The function of...
3.
Chen H, Du H, Yi F, Wang T, Yang S, Pan Y, et al.
Alzheimers Dement
. 2024 Oct;
20(12):8516-8526.
PMID: 39410879
Introduction: Oculomotor and gait dysfunctions are closely associated with cognition. However, oculo-gait patterns and their correlation with cognition in cerebral small vessel disease (CSVD) remain unclear. Methods: Patients with CSVD...
4.
Dong J, Dong H, Xiao J, Li L, Huang D, Zhao M
Environ Sci Technol
. 2024 Jun;
58(27):12179-12188.
PMID: 38913078
Extensive research has been conducted on the utilization of a metal-based catalyst to activate peracetic acid (PAA) for the degradation of micropollutants (MPs) in water. Mn(II) is a commonly employed...
5.
Kong Y, Zhao X, Wang Z, Yuan S, Chen S, Lou S, et al.
Mol Cancer Ther
. 2024 Jun;
:OF1-OF11.
PMID: 38853423
The aberrant activation of FGFR acts as a potent driver of multiple types of human cancers. Despite the development of several conventional small-molecular FGFR inhibitors, their clinical efficacy is largely...
6.
Zhao M, Hu G, Lu Y, Yang Q, Chen X, Wang D, et al.
J Cereb Blood Flow Metab
. 2024 May;
44(11):1302-1315.
PMID: 38749908
Electroencephalogram (EEG) alpha-band oscillations may reflect executive and processing function in patients with cerebral small vessel disease (CSVD). We aimed to assess such association and its relationship with CSVD severity,...
7.
Kong Y, Zhao X, Wang Z, Yuan S, Chen S, Lou S, et al.
Mol Cancer Ther
. 2024 Apr;
PMID: 38647531
The aberrant activation of fibroblast growth factor receptor (FGFR) acts as a potent driver of multiple types of human cancers. Despite the development of several conventional small-molecular FGFR inhibitors, their...
8.
Ma M, Zhao M
ACS Omega
. 2023 Oct;
8(38):34678-34686.
PMID: 37779968
Although the addition of fine particles can enhance mass transfer, the stability of suspension is still a challenge. Responding to this, this study introduced carbon quantum dots (CQDs) with good...
9.
Prevalence and Risk Factors of Cerebral Small Vessel Disease from a Population-Based Cohort in China
Yang Y, Cai X, Zhou M, Chen Y, Pi J, Zhao M, et al.
Neuroepidemiology
. 2023 Sep;
57(6):413-422.
PMID: 37734325
Introduction: Cerebral small vessel disease (CSVD) is a significant burden of morbidity and mortality among elderly people around the world. Epidemiological data with complete CSVD evaluations and a large sample...
10.
Ding J, Liu L, Chiang Y, Zhao M, Liu H, Yang F, et al.
J Med Chem
. 2023 Jun;
66(12):8310-8323.
PMID: 37307526
WDR5 is a critical chromatin cofactor of MYC. WDR5 interacts with MYC through the WBM pocket and is hypothesized to anchor MYC to chromatin through its WIN site. Blocking the...